Machine signal
Active cluster sell — 5 distinct insiders, $1.1M, window ends Sep 29, 2026.
Figures computed from official regulatory filings — .
Analysttarget 18.88 USD (+275%) · consensus 5/5 · 7 buy · 0 hold · 0 sell
Ownershipinsiders 10.96% · institutions 74.9% · short 29.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for ABEONA THERAPEUTICS INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
45 buys136 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| O'Malley Brendan M. | Sell | $34.7K | SEC |
| Seshadri Vishwas | Sell | $101.1K | SEC |
| Vasanthavada Madhav | Sell | $25.3K | SEC |
| Vazzano Joseph Waltertrack record | Sell | $47.4K | SEC |
| Alvino Mark | Sell | $88K | SEC |
| Vazzano Joseph Waltertrack record | Sell | $9.7K | SEC |
| Vasanthavada Madhav | Sell | $87.8K | Unusual size | SEC |
| Vazzano Joseph Waltertrack record | Sell | $173.3K | Unusual size | SEC |
| Seshadri Vishwas | Sell | $473.3K | Unusual size | SEC |
| O'Malley Brendan M. | Sell | $83.9K | SEC |
| Alland Leila | Sell | $65.1K | SEC |
| Vasanthavada Madhav | Other | $1.3K | SEC |
| Silverstein Christine Berni | Sell | $103.7K | SEC |
| Vasanthavada Madhav | Sell | $28.9K | SEC |
| O'Malley Brendan M. | Sell | $26.2K | SEC |
| O'Malley Brendan M. | Sell | $33.4K | SEC |
| Seshadri Vishwas | Sell | $132.6K | SEC |
| Vazzano Joseph Waltertrack record | Sell | $138.3K | SEC |
| Seshadri Vishwas | Sell | $169.3K | SEC |
| Vazzano Joseph Waltertrack record | Sell | $71.2K | SEC |
| Vazzano Joseph Waltertrack record | Sell | $55.8K | SEC |
| Vasanthavada Madhav | Sell | $22.6K | SEC |
| Alvino Mark | Gift | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Alvino Mark | Sell | $35.5K | SEC |
| Crombez Eric | Sell | $144.6K | SEC |